solute carrier family 29 (nucleoside transporters), member 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| neurotransmitter uptake | ||
| neurotransmitter transport | ||
| lactation | ||
| nucleobase transport | ||
| nucleobase transport |
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| basolateral plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| neurotransmitter transmembrane transporter activity | ||
| neurotransmitter transmembrane transporter activity | ||
| nucleoside transmembrane transporter activity | ||
| nucleoside transmembrane transporter activity | ||
| nucleoside transmembrane transporter activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050741 | alcohol dependence | |
| DOID:6652 | diffuse idiopathic skeletal hyperostosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026